112 related articles for article (PubMed ID: 1383484)
1. Alteration of stromal protein and integrin expression in breast--a marker of premalignant change?
Jones JL; Critchley DR; Walker RA
J Pathol; 1992 Aug; 167(4):399-406. PubMed ID: 1383484
[TBL] [Abstract][Full Text] [Related]
2. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast.
Koukoulis GK; Howeedy AA; Korhonen M; Virtanen I; Gould VE
J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813
[TBL] [Abstract][Full Text] [Related]
3. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
[TBL] [Abstract][Full Text] [Related]
4. Integrin expression on normal and neoplastic human breast epithelium.
Damjanovich L; Fülöp B; Adány R; Nemes Z
Acta Chir Hung; 1997; 36(1-4):69-71. PubMed ID: 9408292
[TBL] [Abstract][Full Text] [Related]
5. Tenascin expression in normal and abnormal human endometrium.
Sasano H; Nagura H; Watanabe K; Ito K; Tsuiki A; Sato S; Yajima A; Kusakabe M; Sakakura T
Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462
[TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast.
Gould VE; Koukoulis GK; Virtanen I
Cell Differ Dev; 1990 Dec; 32(3):409-16. PubMed ID: 1711920
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules.
Koukoulis GK; Virtanen I; Korhonen M; Laitinen L; Quaranta V; Gould VE
Am J Pathol; 1991 Oct; 139(4):787-99. PubMed ID: 1928301
[TBL] [Abstract][Full Text] [Related]
8. [Detection of tenascin in stomach cancer. An immunohistochemical study].
Broll R; Kayser K; Vollmer G; Plagemann M; Bruch HP
Zentralbl Pathol; 1994 Jul; 140(2):123-8. PubMed ID: 7524650
[TBL] [Abstract][Full Text] [Related]
9. [Relationship of an extracellular matrix protein, tenascin and breast diseases].
Ishihara A; Yatani R; Sakakura T
Rinsho Byori; 1993 Oct; 41(10):1099-107. PubMed ID: 7504753
[TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
[TBL] [Abstract][Full Text] [Related]
11. Modulation of myoepithelial-associated alpha6beta4 integrin in a breast cancer cell line alters invasive potential.
Jones JL; Royall JE; Critchley DR; Walker RA
Exp Cell Res; 1997 Sep; 235(2):325-33. PubMed ID: 9299156
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
[TBL] [Abstract][Full Text] [Related]
13. Beta 1 and beta 4 integrin expression in methacarn and formalin-fixed material from in situ ductal carcinoma of the breast.
Hanby AM; Gillett CE; Pignatelli M; Stamp GW
J Pathol; 1993 Dec; 171(4):257-62. PubMed ID: 7512643
[TBL] [Abstract][Full Text] [Related]
14. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases.
Gusterson BA; Warburton MJ; Mitchell D; Ellison M; Neville AM; Rudland PS
Cancer Res; 1982 Nov; 42(11):4763-70. PubMed ID: 6290045
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical study of oncogene c-erbb-2 expression and extracellular matrix proteins in breast cancer (various mechanisms of invasion)].
Pozharisskiĭi KM; Kyshtoobaeva ASh; Turkevich EA
Arkh Patol; 1997; 59(4):19-25. PubMed ID: 9334150
[TBL] [Abstract][Full Text] [Related]
16. Tenascin staining positivity and the survival of patients with invasive breast carcinoma.
Shoji T; Kamiya T; Tsubura A; Hamada Y; Hatano T; Hioki K; Morii S
J Surg Res; 1993 Sep; 55(3):295-7. PubMed ID: 7692137
[TBL] [Abstract][Full Text] [Related]
17. Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors.
Droz D; Patey N; Paraf F; Chrétien Y; Gogusev J
Lab Invest; 1994 Nov; 71(5):710-8. PubMed ID: 7526040
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer.
Moch H; Torhorst J; Dürmüller U; Feichter GE; Sauter G; Gudat F
Pathol Res Pract; 1993 Jun; 189(5):510-4. PubMed ID: 7690952
[TBL] [Abstract][Full Text] [Related]
19. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
Tuszynski GP; Nicosia RF
Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
[TBL] [Abstract][Full Text] [Related]
20. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
